Document is current
Any future updates will be listed below
-
Authors
Baertsch, Marc-Andrea http://orcid.org/0000-0002-4000-6904
Mai, Elias K. http://orcid.org/0000-0002-6226-1252
Hielscher, Thomas
Bertsch, Uta
Salwender, Hans J.
Munder, Markus
Fuhrmann, Stephan http://orcid.org/0000-0002-7785-2565
Dührsen, Ulrich
Brossart, Peter
Neben, Kai
Schlenzka, Jana
Kunz, Christina
Raab, Marc S.
Hillengaß, Jens
Jauch, Anna
Seckinger, Anja
Hose, Dirk
Luntz, Steffen
Sonneveld, Pieter
Lokhorst, Henk
Martin, Hans
Goerner, Martin
Hoffmann, Martin
Lindemann, Hans-Walter
Bernhard, Helga
Blau, Igor W.
Scheid, Christof
Besemer, Britta
Weisel, Katja C. http://orcid.org/0000-0001-9422-6614
Hänel, Mathias
Dürig, Jan
Goldschmidt, Hartmut http://orcid.org/0000-0003-0961-0035
,
- License Information
-
More Information
Article History
Received: 16 July 2020
Revised: 29 October 2020
Accepted: 10 November 2020
First Online: 7 January 2021
Conflict of interest
: MAB: Takeda: Consultancy, honoraria; Novartis: Consultancy, Research Funding; Celgene, Amgen, Janssen: Travel grants. EKM: honoraria: Janssen, Celgene, Takeda; consulting or advisory role: Janssen, Celgene, Takeda; research funding: Takeda; travel, accommodations, expenses: Janssen, Takeda, Celgene, Mundipharma. TH: no COI. UB: no COI. HJS: Amgen: Honoraria, Other: Travel or accommodations; Bristol-Myers Squibb: Honoraria, Other: Travel or accommodations; Janssen Cilag: Honoraria, Other: Travel or accommodations; Sanofi: Honoraria, Other: Travel or accommodations; Celgene: Honoraria, Other: Travel or accommodations; AbbVie: Honoraria; Takeda: Honoraria, Other: Travel or accommodations. MMu: honoraria: Janssen, BMS, Takeda, Celgene, Amgen; consulting or advisory role: Janssen, BMS, Takeda, Celgene, Amgen; research funding: BMS; travel, accomodations, expenses: Janssen, BMS, Takeda, Amgen. SF: Advisory board: BMS, Celgene und Amgen. UD: Alexion: Honoraria; Janssen: Honoraria. PB: consulting or advisory role: BMS, AMGEN, Roche, MSD; research funding: BMS; travel, accomodations, expenses: BMS. KN: no COI. JS: no COI. CK: no COI. MSR: honoraria: Celgene, BMS,Novartis, Janssen, Takeda; consulting or advisory role: Celgene, BMS,Novartis, Janssen, Takeda; research funding: Celgene, Novartis, AMGEN; travel, accomodations, expenses: Janssen, BMS, Takeda. JH: Advisory boards: Adaptive, Amgen, BMS, Celgene, GSK, Janssen, Oncotracker. AJ: no COI. AS: no COI. DH: no COI. SL: no COI. PS: SkylineDx: Membership on an entity’s Board of Directors or advisory committees; Karyopharm: Research Funding; Amgen: Honoraria, Research Funding; Celgene: Honoraria, Research Funding; Janssen: Honoraria, Research Funding. HL: Janssen: Honoraria, Research Funding; Genmab: Honoraria, Research Funding; Amgen: Honoraria. HM: no COI. MG: no COI. MHo: honoraria: MSD. HWL: no COI. HB: no COI. IWB: research funding: Celgene, BMS, Janssen. CS: honoraria: BMS, Janssen, Celgene, Novartis, Amgen, Takeda; consulting or advisory role: BMS, Janssen, Celgene, Novartis, Amgen, Takeda; speakers bureau: Takeda; research funding: Takeda, Novartis; travel, accomodations, expenses: BMS, Janssen, Celgene, Novartis, Amgen, Takeda. BB: no COI. KCW: honoraria: AMGEN, BMS, Celgene, Novartis, Janssen, Takeda; consulting or advisory role: AMGEN, BMS, Celgene, Juno, Janssen, Adaptive, Sanofi, Takeda; research funding: AMGEN, Celgene, Sanofi, Janssen. MHä: honoraria: Novartis, Amgen, Roche, Takeda; consulting or advisory role: Celgene. JD: consulting or advisory role: Celgene; speakers bureau: Celgene; travel, accomodations, expenses: Celgene. HG: honoraria: Amgen, BMS, Celgene, Chugai, Janssen, Novartis, Takeda; consulting or advisory role: Amgen, BMS, Celgene, Chugai, Janssen, Novartis, Takeda; speakers bureau: Amgen, BMS, Celgene, Janssen, Novartis, Takeda; research funding: Amgen, BMS, Celgene, Chugai, Janssen, Novartis, Takeda; travel, accomodations, expenses: BMS, Celgene, Janssen, Novartis, Takeda.
